The content on this site is intended for healthcare professionals only
Prof Eggermont hosts a press conference at ESMO 2014 about the Cancer Core Europe initiative, which looks to collate data and research from six key European cancer centres to create a fully integrated and collaborative 'e-hospital'.
Here, Eggermont gives an overview of the Institut Gustave Roussy and its place within the Cancer Core Europe initiative.
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Gaps in the workforce delivering cancer care
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML
